Literature DB >> 27783749

Primary graft dysfunction of the liver: definitions, diagnostic criteria and risk factors.

Douglas Bastos Neves1,2, Marcela Balbo Rusi3, Luiz Gustavo Guedes Diaz3, Paolo Salvalaggio3.   

Abstract

Primary graft dysfunction is a multifactorial syndrome with great impact on liver transplantation outcomes. This review article was based on studies published between January 1980 and June 2015 and retrieved from PubMed database using the following search terms: "primary graft dysfunction", "early allograft dysfunction", "primary non-function" and "liver transplantation". Graft dysfunction describes different grades of graft ischemia-reperfusion injury and can manifest as early allograft dysfunction or primary graft non-function, its most severe form. Donor-, surgery- and recipient-related factors have been associated with this syndrome. Primary graft dysfunction definition, diagnostic criteria and risk factors differ between studies. RESUMO A disfunção primária do enxerto hepático é uma síndrome multifatorial com grande impacto no resultado do transplante de fígado. Foi realizada uma ampla revisão da literatura, consultando a base de dados PubMed, em busca de estudos publicados entre janeiro de 1980 e junho de 2015. Os termos descritivos utilizados foram: "primary graft dysfunction", "early allograft dysfunction", "primary non-function" e "liver transplantation". A disfunção traduz graus diferentes da lesão de isquemia e reperfusão do órgão, e pode se manifestar como disfunção precoce ou, na forma mais grave, pelo não funcionamento primário do enxerto. Fatores relacionados ao doador, ao transplante e ao receptor contribuem para essa síndrome. Existem definições diferentes na literatura quanto ao diagnóstico e aos fatores de risco associados à disfunção primária.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27783749     DOI: 10.1590/S1679-45082016RW3585

Source DB:  PubMed          Journal:  Einstein (Sao Paulo)        ISSN: 1679-4508


  14 in total

1.  A panel of biomarkers in the prediction for early allograft dysfunction and mortality after living donor liver transplantation.

Authors:  Hsin-I Tsai; Chi-Jen Lo; Chao-Wei Lee; Jr-Rung Lin; Wei-Chen Lee; Hung-Yao Ho; Chia-Yi Tsai; Mei-Ling Cheng; Huang-Ping Yu
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

2.  Postreperfusion Liver Biopsy as Predictor of Early Graft Dysfunction and Survival After Orthotopic Liver Transplantation.

Authors:  Esteban Fuentes-Valenzuela; Javier Tejedor-Tejada; Félix García-Pajares; Beatriz M Rubiales; Rodrigo Nájera-Muñoz; Carlos Maroto-Martín; Laura Sánchez-Delgado; Carmen Alonso-Martín; Carolina A Álvarez; Gloria Sánchez-Antolín
Journal:  J Clin Exp Hepatol       Date:  2022-01-04

3.  Transplantation of Extended Criteria Donor Livers Following Continuous Normothermic Machine Perfusion Without Recooling.

Authors:  Zhitao Chen; Tielong Wang; Chuanbao Chen; Qiang Zhao; Yihao Ma; Yiwen Guo; Xitao Hong; Jia Yu; Changjun Huang; Weiqiang Ju; Maogen Chen; Xiaoshun He
Journal:  Transplantation       Date:  2022-09-07       Impact factor: 5.385

4.  Effect of Donor Hepatic Steatosis on Ischemia Reperfusion Injury in Liver Transplant Recipient.

Authors:  Prafulla V Jadhav; Sunil Raviraj Kothakota; Madhu Sasidharan; Harish Kareem; Ajith K Nair
Journal:  J Clin Exp Hepatol       Date:  2019-07-12

5.  Study design of the DAS-OLT trial: a randomized controlled trial to evaluate the impact of dexmedetomidine on early allograft dysfunction following liver transplantation.

Authors:  Chenlu Ni; Joe Masters; Ling Zhu; Weifeng Yu; Yingfu Jiao; Yuting Yang; Cui Cui; Suqing Yin; Liqun Yang; Bo Qi; Daqing Ma
Journal:  Trials       Date:  2020-06-26       Impact factor: 2.279

Review 6.  Ubiquitin-proteasome system and oxidative stress in liver transplantation.

Authors:  Norma Alva; Arnau Panisello-Roselló; Marta Flores; Joan Roselló-Catafau; Teresa Carbonell
Journal:  World J Gastroenterol       Date:  2018-08-21       Impact factor: 5.742

7.  Evaluation of bioenergetic and mitochondrial function in liver transplantation.

Authors:  Rui Miguel Martins; João Soeiro Teodoro; Emanuel Furtado; Anabela Pinto Rolo; Carlos Marques Palmeira; José Guilherme Tralhão
Journal:  Clin Mol Hepatol       Date:  2019-03-22

Review 8.  Minimizing Ischemia Reperfusion Injury in Xenotransplantation.

Authors:  Parth M Patel; Margaret R Connolly; Taylor M Coe; Anthony Calhoun; Franziska Pollok; James F Markmann; Lars Burdorf; Agnes Azimzadeh; Joren C Madsen; Richard N Pierson
Journal:  Front Immunol       Date:  2021-09-09       Impact factor: 7.561

9.  Prospective, single-centre, randomised controlled trial to evaluate the efficacy and safety of ischaemia-free liver transplantation (IFLT) in the treatment of end-stage liver disease.

Authors:  Changjun Huang; Shanzhou Huang; Yunhua Tang; Qiang Zhao; Dongping Wang; Weiqiang Ju; Lu Yang; Jian Zhang; Linwei Wu; Maogen Chen; Zhiheng Zhang; Zebin Zhu; Linhe Wang; Caihui Zhu; Yixi Zhang; Chengjun Sun; Wei Xiong; Yuekun Shen; Xiaoxiang Chen; Yi Ma; Anbin Hu; Xiaofeng Zhu; Jian Rong; Changjie Cai; Zhiyong Guo; Xiaoshun He
Journal:  BMJ Open       Date:  2020-05-05       Impact factor: 2.692

10.  The postoperative hepatic artery resistance index after living donor liver transplantation can predict early allograft dysfunction.

Authors:  Tao Lv; LingXiang Kong; Jiayin Yang; Hong Wu; Tianfu Wen; Li Jiang; Jian Yang
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.